Analysts at Canaccord Genuity started coverage on shares of TSO3 Inc. (TSE:TOS) in a note issued to investors on Wednesday, AnalystRatings.Net reports. The firm set a “buy” rating and a C$3.25 price target on the stock. Canaccord Genuity’s price target indicates a potential upside of 71.05% from the company’s previous close.

TSO3 (TSE:TOS) opened at 1.90 on Wednesday. The firm’s market cap is $158.20 million. The stock’s 50 day moving average is $2.00 and its 200-day moving average is $1.86. TSO3 has a 1-year low of $1.13 and a 1-year high of $2.25.

TOS has been the topic of a number of other reports. Desjardins lifted their target price on TSO3 from C$3.25 to C$4.40 in a report on Thursday, November 26th. M Partners lifted their target price on TSO3 from C$3.50 to C$4.00 in a report on Friday, November 27th.

TSO3 inc. encompasses the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment that offer an advantageous replacement solution to other low temperature sterilization processes used in hospitals. It also offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes. The Company’s products include STERIZONE 125L+ Sterilizers. The single cycle of the STERIZONE VP4 Sterilizer can sterilize a number and range of compatible devices.

Receive News & Ratings for TSO3 Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TSO3 Inc. and related companies with MarketBeat.com's FREE daily email newsletter.